PTN_OUT_1 [2025-04-16 13:16:54 -0400] 4370 Bytes | 1197 tokens | Cum: 1197 tkns (14.96% of 8k)
==========================================================================

You're the expert here today. So, I pulled together a bunch of data for you to look over real fast. I'm looking at high-performance stocks today and Palatin Technologies (PTN) hit my radar screen, up to 0.2496 from a prev close of 0.2053 Do you think its got more juice or is it lacking potential? It's 1:16:53 PM on Wed Apr 16, 2025 -0400 and I have to decide: buy or sell!

--- COMPANY PROFILE ---
Company: Palatin Technologies (PTN)
IPO: 1993-11-04 (31 Years Ago)
Market Cap: $12,763,669
Shares Outstanding: 26,010,000
Industry: PHARMACEUTICAL PREPARATIONS
Exchange: XASE
Description: Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.

Here’s a list of headlines for Palatin Technologies:

Apr-14-25 07:00AM - Palatin Appeals NYSE American Notice of Delisting
Apr-10-25 04:01PM - Palatin Technologies, Inc. Announces Receipt of NYSE American Notice of Delisting and Intention to Appeal
Apr-10-25 04:01PM 07:30AM - Palatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Spring Meeting
Mar-31-25 07:30AM - Palatin Announces MC4R Agonist Bremelanotide Co-Administered with GLP-1/GIP Tirzepatide Meets Primary Endpoint in Phase 2 Obesity Study
Mar-28-25 01:11PM - Palatins UC therapy prompts clinical remission in a third of patients
Mar-28-25 01:11PM 07:30AM - Palatin Announces Positive Topline Results from Phase 2 Ulcerative Colitis (UC) Study of Oral Melanocortin-1 Receptor Agonist PL8177
Mar-25-25 07:30AM - Palatin's Oral MC4R Agonist PL7737 Receives FDA Orphan Drug Designation for Obesity Due to Leptin Receptor Deficiency
Mar-13-25 09:55AM - Here's Why Palatin Technologies (PTN) Is a Great 'Buy the Bottom' Stock Now

Prior AI Reports for PTN:
1. 2025-03-25 – Score: 30 – Target: 0.8280 – Highs: 0.8349 / 0.7744 / 0.74
palatin-technologies-faces-risk-amid-high-volatility-and-sales-decline

(Note: Highs = Same day / 2nd day / 3rd day)

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2025-02-09T21:40:00Z - Data la crescita esponenziale del settore del turismo in Arabia Saudita, dmg events annuncia il salone Hotel & Hospitality Expo
B2 - 2025-02-07T06:38:00Z - As Saudi Arabia’s Tourism Sector Grows Exponentially, dmg events Announces Hotel & Hospitality Expo
B3 - 2024-05-20T16:00:08Z - Palatin Technologies (PTN) Upgraded to Buy: What Does It Mean for the Stock?
B4 - 2024-04-12T12:36:12Z - Palatin Technologies And 2 Other Stocks Under $3 Insiders Are Buying
B5 - 2024-04-09T12:59:00Z - Palatin (PTN) Up 15% on Results From Dry Eye Disease Study
B6 - 2024-02-28T19:02:02Z - Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Palatin Technologies (PTN).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

PTN_OUT_3 [2025-04-16 13:16:56 -0400] 679 Bytes | 186 tokens | Cum: 1385 tkns (17.31% of 8k)
==========================================================================

Showing B3 (chunk 1 of 1): B3:
**Palatin Technologies (PTN) Upgraded to Buy: What Does It Mean for the Stock?**Date: Unknown DateSource: Unknown SourceURL: https://www.zacks.com/stock/news/2276232/palatin-technologies-ptn-upgraded-to-buy-what-does-it-mean-for-the-stockPalatin Technologies (PTN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

PTN_OUT_5 [2025-04-16 13:16:56 -0400] 933 Bytes | 277 tokens | Cum: 1664 tkns (20.80% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-14T20:34:00Z - Palatin Appeals NYSE Delisting, Pursues Financing And Partnerships To Regain Compliance...
A2 - 2025-04-14T20:48:00Z - Palatin Appeals NYSE Delisting, Pursues Financing And Partnerships To Regain Compliance...
A3 - 2025-04-14T11:08:39Z - Palatin contests NYSE American delisting notice By Investing.com...
A4 - 2025-04-14T02:18:42Z - Top 3 Biotech Stocks That Got Retail Street Buzzing Last Week: SMMT, PTN, RXRX...
A5 - 2025-04-14T02:30:05Z - Top 3 Biotech Stocks That Got Retail Street Buzzing Last Week: SMMT, PTN, RXRX...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

PTN_OUT_7 [2025-04-16 13:16:57 -0400] 1181 Bytes | 292 tokens | Cum: 1958 tkns (24.47% of 8k)
==========================================================================

Showing A1 (chunk 1 of 2): A1:
**Palatin Appeals NYSE Delisting, Pursues Financing And Partnerships To Regain Compliance**Date: 2025-04-14Source: {'uri': 'nasdaq.com', 'dataType': 'news', 'title': 'NASDAQ Stock Market'}URL: https://www.nasdaq.com/articles/palatin-appeals-nyse-delisting-pursues-financing-and-partnerships-regain-compliance(RTTNews) - Palatin Technologies, Inc. (PTN) Monday announced that it has appealed the NYSE American's decision to delist its stock after failing to meet stockholders' equity requirements by the April 10, 2025 deadline.

While the stock continues to trade during the 60-90 day appeal process, a final ruling will determine its listing status.

The company is actively pursuing out-licensing deals, equity financing, and strategic funding to improve its financial position. CEO Carl Spana emphasized confidence in restoring compliance and building a stronger foundation for growth, though

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

PTN_OUT_9 [2025-04-16 13:17:00 -0400] 536 Bytes | 141 tokens | Cum: 2101 tkns (26.26% of 8k)
==========================================================================

Showing A1 (chunk 2 of 2): success of the appeal remains uncertain.

PTN is currently trading at $0.2075 or 25.7576% higher on the NYSE American.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

PTN_OUT_11 [2025-04-16 13:17:01 -0400] 1059 Bytes | 346 tokens | Cum: 2449 tkns (30.61% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-02-13 10-Q PART I FIN INFO

Item 1. Fin Stmnts.

PALATIN TECHNOLOGIES, INC .

and Subsidiary

Cons Balance Sheets

(unaudited)

December 31, 2024

June 30, 2024

ASSETS

Curr assets:

Cash and cash equiv

$ 3,416,604

$ 9,527,396

Prepaid e...

S2 - 2025-02-13 10-Q PART I FIN INFO

Item 1. Fin Stmnts.

PALATIN TECHNOLOGIES, INC .

and Subsidiary

Cons Balance Sheets

(unaudited)

December 31, 2024

June 30, 2024

ASSETS

Curr assets:

Cash and cash equiv

$ 3,416,604

$ 9,527,396

Prepaid e...

S3 - 2025-02-11 8-K Item 1.01 Entry into a Material Definitive Agrmt.

On February 11, 2025, Palatin Technologies, Inc. (the Company) entered into an At the Market Issuance Sales Agrmt (the Sales Agrmt), with A.G.P./Alliance Global Partners (A.G.P.), pursuant to which the Company may, f...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

PTN_OUT_13 [2025-04-16 13:17:02 -0400] 1181 Bytes | 357 tokens | Cum: 2808 tkns (35.10% of 8k)
==========================================================================

Showing S1 (chunk 1 of 6): S1:
PART I FINANCIAL INFORMATION

Item 1. Financial Statements.

PALATIN TECHNOLOGIES, INC .

and Subsidiary

Consolidated Balance Sheets

(unaudited)

December 31, 2024

June 30, 2024

ASSETS

Current assets:

Cash and cash equivalents

$ 3,416,604

$ 9,527,396

Prepaid expenses and other current assets

253,113

242,272

Total current assets

3,669,717

9,769,668

Property and equipment, net

235,741

388,361

Right-of-use assets - operating leases

347,644

527,321

Other assets

56,916

56,916

Total assets

$ 4,310,018

$ 10,742,266

LIABILITIES AND STOCKHOLDERS DEFICIENCY

Current liabilities:

Accounts payable

$ 6,718,233

$ 4,101,929

Accrued expenses

1,650,700

4,185,046

Short-term operating lease liabilities

257,673

380,542

Short-term finance lease liabilities

-

46,014

Other current liabilities

932,150

944,150

Total current liabiliti

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

PTN_OUT_15 [2025-04-16 13:17:04 -0400] 1181 Bytes | 360 tokens | Cum: 3170 tkns (39.62% of 8k)
==========================================================================

Showing S1 (chunk 2 of 6): es

9,558,756

9,657,681

Long-term operating lease liabilities

100,071

163,782

Other long-term liabilities

1,032,300

1,032,300

Total liabilities

10,691,127

10,853,763

Commitments and contingencies (Note 12)

Stockholders deficiency:

Preferred stock of $ 0.01 par value authorized 10,000,000 shares: shares issued and outstanding designated as follows:

Series A Convertible: authorized 4,030 shares as of December 31, 2024: issued and outstanding 4,030 shares as of December 31, 2024 and June 30, 2024

40

40

Common stock of $ 0.01 par value authorized 300,000,000 shares:

issued and outstanding 23,455,846 shares as of December 31, 2024 and 17,926,640 shares as of June 30, 2024

234,558

179,266

Additional paid-in capital

445,416,974

441,475,747

Accumulated deficit

( 452,032,681 )

( 441,766,550 ) Total stockholders deficiency

( 6,381,109 )

( 111,497 ) Total

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

PTN_OUT_17 [2025-04-16 13:17:05 -0400] 1181 Bytes | 392 tokens | Cum: 3564 tkns (44.55% of 8k)
==========================================================================

Showing S1 (chunk 3 of 6): liabilities and stockholders deficiency

$ 4,310,018

$ 10,742,266

The accompanying notes are an integral part of these consolidated financial statements.

1

PALATIN TECHNOLOGIES, INC.

and Subsidiary

Consolidated Statements of Operations

(unaudited)

Three Months Ended December 31

Six Months Ended December 31

REVENUES

Product revenue, net

$ -

$ 2,034,113

$ -

$ 4,140,090

OPERATING EXPENSES

Cost of products sold

-

97,637

-

97,637

Research and development

3,429,479

5,554,200

9,173,233

10,568,830

Selling, general and administrative

1,681,844

3,032,613

3,702,775

6,232,857

Gain on sale of Vyleesi

( 2,500,000 )

( 7,823,482 )

( 2,500,000 )

( 7,823,482 ) Total operating expenses

2,611,323

860,968

10,376,008

9,075,842

(Loss) Income from operations

( 2,611,323 )

1,173,145

( 10,376,008 )

( 4,935,752 )

OTHER INCOME (EXPEN

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

PTN_OUT_19 [2025-04-16 13:17:06 -0400] 1181 Bytes | 397 tokens | Cum: 3963 tkns (49.54% of 8k)
==========================================================================

Showing S1 (chunk 4 of 6): SE)

Investment income

29,044

62,026

107,620

133,656

Foreign currency transaction gain (loss)

143,600

( 306,697 )

12,000

( 146,947 ) Interest expense

( 3,803 )

( 1,605 )

( 9,743 )

( 12,487 ) Offering expenses

-

( 696,912 )

-

( 696,912 ) Change in fair value of warrant liabilities

-

( 8,073,991 )

-

( 7,391,591 ) Total other income (expense), net

168,841

( 9,017,179 )

109,877

( 8,114,281 )

NET LOSS

$ ( 2,442,482 )

$ ( 7,844,034 )

$ ( 10,266,131 )

$ ( 13,050,033 )

Basic and diluted net loss per common share

$ ( 0.12 )

$ ( 0.56 )

$ ( 0.51 )

$ ( 0.99 )

Weighted average number of common shares outstanding used in computing basic and diluted net loss per common share

20,634,887

14,097,757

20,239,997

13,134,228

The accompanying notes are an integral part of these consolidated financial statements.

2

PALATIN TECHNOLOGIES

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

PTN_OUT_21 [2025-04-16 13:17:07 -0400] 1181 Bytes | 384 tokens | Cum: 4349 tkns (54.36% of 8k)
==========================================================================

Showing S1 (chunk 5 of 6): , INC.

and Subsidiary

Consolidated Statements of Changes in Stockholders Deficiency

(unaudited)

Three Months Ended December 31, 2024

Stockholders' Deficiency

Series A Convertible

Preferred Stock

Common

Stock

Additional

Paid-in

Accumulated

Shares

Amount

Shares

Amount

Capital

Deficit

Total

Balance September 30, 2024

4,030

$ 40

19,548,167

$ 195,481

$ 441,709,073

$ ( 449,590,199 )

$ ( 7,685,605 ) Stock-based compensation

-

-

-

-

348,955

-

348,955

Warrant exercises

-

-

3,907,679

39,077

3,358,946

-

3,398,023

Net loss

-

-

-

-

-

( 2,442,482 )

( 2,442,482 ) Balance December 31, 2024

4,030

40

23,455,846

234,558

445,416,974

( 452,032,681 )

( 6,381,109 )

Six Months Ended December 31, 2024

Stockholders' Deficiency

Series A Convertible

Preferred Stock

Common

Stock

Additional

Paid

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

PTN_OUT_23 [2025-04-16 13:17:07 -0400] 790 Bytes | 271 tokens | Cum: 4622 tkns (57.77% of 8k)
==========================================================================

Showing S1 (chunk 6 of 6): -in

Accumulated

Shares

Amount

Shares

Amount

Capital

Deficit

Total

Balance June 30, 2024

4,030

$ 40

17,926,640

$ 179,266

$ 441,475,747

$ ( 441,766,550 )

$ ( 111,497 ) Stock-based compensation

-

-

232,941

2,329

695,649

-

697,978

Withholding taxes related to restricted stock units

-

-

( 54,691 )

( 547 )

( 98,935 )

-

( 99,482 ) Shares released from abeyance

-

-

1,443,277

14,433

( 14,433 )

-

-

Warrant exercises

-

-

3,907,679

...

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

PTN_OUT_25 [2025-04-16 13:17:15 -0400] 5900 Bytes | 1537 tokens | Cum: 6161 tkns (77.01% of 8k)
==========================================================================

This is our set of metrics for Palatin Technologies.
Please analyze the numbers.

+--------------------+-----------------------+-------------------------+------------------------+
| Volume: 2,949,929 | Perf Month: -69.76% | Option/Short: Yes / Yes | Sales Y/Y TTM: -95.07% |
+--------------------+-----------------------+-------------------------+------------------------+
| Avg Volume: 1.99M | Perf Quarter: -77.74% | Short Float: 9.25% | ROE: 303.40% |
+--------------------+-----------------------+-------------------------+------------------------+
| Rel Volume: 2.62 | Index: - | Short Ratio: 1.17 | ROI: - |
+--------------------+-----------------------+-------------------------+------------------------+
| RSI (14): 24.24 | Market Cap: 6.25M | Short Interest: 2.34M | Sales Surprise: - |
+--------------------+-----------------------+-------------------------+------------------------+
| ATR (14): 0.09 | Shs Outstand: 26.01M | Beta: 1.07 | EPS Surprise: 71.43% |
+--------------------+-----------------------+-------------------------+------------------------+
| SMA20: -53.74% | Shs Float: 25.32M | Sales Q/Q: - | P/E: - |
+--------------------+-----------------------+-------------------------+------------------------+
| SMA50: -67.91% | Inst Own: 6.50% | Sales past 5Y: -40.50% | Earnings: Feb 13 BMO |
+--------------------+-----------------------+-------------------------+------------------------+
| SMA200: -78.38% | Insider Own: 1.80% | Employees: 30 | |
+--------------------+-----------------------+-------------------------+------------------------+
| Perf Week: -45.61% | Insider Trans: 0.00% | Debt/Eq: - | |
+--------------------+-----------------------+-------------------------+------------------------+

The next section covers any insider trading by Palatin Technologies officers or majority shareholders (if available).

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 1809371.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -26952211.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.2496
Average Volume: 3707568.3
30-Day High: 0.8101
30-Day Low: 0.165

[Detailed Financials: Q2 2025]
- Total Assets: $4,310,018.0
- Total Liabilities: $10,691,127.0
- Total Equity: $-6,381,109.0
- Current Assets: $3,669,717.0
- Current Liabilities: $9,558,756.0

[Income Statement: Q2 2025]
- Revenue: $0.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.12

[Cash Flow Statement: Q2 2025]
- Net Cash Flow: $-6,110,792.0

[Detailed Financials: Q1 2025]
- Total Assets: $3,415,259.0
- Total Liabilities: $11,100,864.0
- Total Equity: $-7,685,605.0
- Current Assets: $2,612,649.0
- Current Liabilities: $9,861,717.0

[Income Statement: Q1 2025]
- Revenue: $1,459,371.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.39

[Cash Flow Statement: Q1 2025]
- Net Cash Flow: $0
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Palatin Technologies (PTN).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Palatin Technologies.

2) MARKET_SCORE[]
This conversation was initiated because PTN is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for PTN.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, PTN could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect PTN to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Palatin Technologies.

11) ETHICAL_RATING[]
Rate Palatin Technologies’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Palatin Technologies.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

PTN_IN_27 [2025-04-16 13:17:16 -0400] 126 Bytes | 29 tokens | Cum: 6413 tkns (80.16% of 8k)
==========================================================================

====================================
[2025-04-16 13:17:16] # Analysis Completed
Elapsed Time: 22.55 seconds